AquaBounty Technologies Inc (AQB)
NASDAQ:AQB
AQB Stock Chart & Stats
$0.96
-$0.09(-10.49%)
At close: 4:00 PM EST
$0.96
-$0.09(-10.49%)
Day’s Range― - ―
52-Week Range$0.60 - $2.95
Previous CloseN/A
Volume79.08K
Average Volume (3M)1.58M
Market Cap
$4.56M
Enterprise Value-$497.86M
Total Cash (Recent Filing)$501.30M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.65
Shares Outstanding5,147,204
10 Day Avg. Volume221,557
30 Day Avg. Volume1,577,744
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)>-0.01
Price to Sales (P/S)0.00
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-109.29
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-7.28
Revenue Forecast (FY)$500.00K
Bulls Say, Bears Say
Bulls Say
Proprietary Genetic Tech & Land-based RASAquaBounty's proprietary genetic modification plus land-based recirculating aquaculture systems (RAS) provide a durable competitive edge: faster-growing salmon, controlled biosecurity, and production predictability. These structural advantages support long-term scalability, product differentiation, and reduced disease exposure versus open-net pens.
Vertically Integrated Production ModelControl over hatchery, breeding and grow-out activities creates an integrated supply chain that supports yield improvements, survival management and cost control. This structural model enhances ability to scale output, capture more value per fish, and sustain margins if harvest volumes and operational efficiency improve.
Access To Capital MarketsThe recent registered direct offering shows the company can tap institutional capital to fund operations and working capital needs. For a cash-burning biotech/aquaculture operator, demonstrated market access is a lasting operational lifeline that underpins near-term continuity and the ability to pursue incremental ramp or facility investments.
Bears Say
Collapsed RevenueRevenue collapsing to near zero removes operating leverage and market validation for the core product. Over a sustained period this undermines the firm's ability to cover fixed costs and invest in growth, signaling structural demand, production, or commercialization failures that impair long-term viability absent a clear recovery plan.
Persistent Negative Cash FlowConsistent negative operating and free cash flow reflects structural inability to self-fund operations. Ongoing cash burn forces repeated reliance on external financing, increases dilution risk, and constrains capital allocation for capacity, maintenance, or product development, heightening liquidity risk over the medium term.
Negative Stockholders' EquityA negative equity position usually reflects accumulated losses or write-downs and materially increases financial distress risk. It weakens creditor and investor confidence, limits financing options, and can impair strategic flexibility, making recovery more difficult even if operations improve.
AquaBounty Technologies News
AQB FAQ
What was AquaBounty Technologies Inc’s price range in the past 12 months?
AquaBounty Technologies Inc lowest stock price was $0.60 and its highest was $2.95 in the past 12 months.
What is AquaBounty Technologies Inc’s market cap?
AquaBounty Technologies Inc’s market cap is $4.56M.
When is AquaBounty Technologies Inc’s upcoming earnings report date?
AquaBounty Technologies Inc’s upcoming earnings report date is Apr 30, 2026 which is in 28 days.
How were AquaBounty Technologies Inc’s earnings last quarter?
AquaBounty Technologies Inc released its earnings results on Mar 10, 2026. The company reported -$3.646 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.646.
Is AquaBounty Technologies Inc overvalued?
According to Wall Street analysts AquaBounty Technologies Inc’s price is currently Overvalued.
Does AquaBounty Technologies Inc pay dividends?
AquaBounty Technologies Inc does not currently pay dividends.
What is AquaBounty Technologies Inc’s EPS estimate?
AquaBounty Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AquaBounty Technologies Inc have?
AquaBounty Technologies Inc has 5,147,204 shares outstanding.
What happened to AquaBounty Technologies Inc’s price movement after its last earnings report?
AquaBounty Technologies Inc reported an EPS of -$3.646 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.667%.
Which hedge fund is a major shareholder of AquaBounty Technologies Inc?
Currently, no hedge funds are holding shares in AQB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AquaBounty Technologies Inc
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
Technical Analysis
Ownership Overview
―
Insiders
1.72% Mutual Funds
2.83% Other Institutional Investors
94.85% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---